Sandalwood oil, rich in sesquiterpenoid alcohols, has been used in traditional medicinal systems as a relaxant and coolant. Besides, sandalwood oil is used as an ingredient in numerous skin fairness enhancing cosmetics. However, there is no available information on biological activities that relate to the above applications. Hence, the anti-tyrosinase and anti-cholinesterase potentials of sandalwood oil were probed by both TLC-bioautographic and colorimetric methods. Results obtained from colorimetric assays indicated that sandalwood oil is a potent inhibitor of tyrosinase (IC 50 =171 µg mL -1 ) and cholinesterases (IC 50 =4.8-58 µg mL -1 ), in comparison with the positive controls used in the assays, kojic acid and physostigmine, respectively. The TLC-bioautographic assays indicated that α-santalol, the major constituent of the oil, is a strong inhibitor of both tyrosinase and cholinesterase. These in vitro results indicate that there is a great potential of this essential oil for use in the treatment of Alzheimer's disease, as well as in skin-care.
The East Indian Sandalwood tree, Santalum album L., is a woody and tropical species belonging to the Santalaceae. The heartwood deposited essential oil is a mixture of bioactive sesquiterpenoid alcohols (santalols), i.e. ~ 90%. The oil is obtained commercially from the steam distillate of wood in yields of 2.5-6%. Sandalwood oil finds extensive applications in Ayurveda owing to its proven biological activities [1] .
Alzheimer's disease (AD) is the most common neurodegenerative disease that affects the elderly through progressive memory loss, decline in language skills and other serious cognitive impairments [2] . Acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) inhibitors are the first group of drugs approved by the FDA to treat AD. Most of these drugs, such as huperzine, rivastigmine, phenserine, and galanthamine, are alkaloids of plant-origin and act by increasing the endogenous levels of acetylcholine to boost cholinergic neurotransmission [3] . Reports on anticholinestarase activity of essential oils are rare, but Salvia essential oils have been reported for the treatment of AD [4] . In this regards, discovery of new, effective, and safer compounds from plants with anti-cholinesterase activity is of great interest.
Traditional use of plants against skin disease, for cosmetic and pharmaceutical purposes in domestic medicine of ancient and contemporary cultures led to the discovery of potential antipigmentation and hyperpigmentation molecules [5] , which are used in cosmetic and medicinal applications. Melanin in skin provides a defense mechanism against the UV-light of the sun, whereas abnormal pigmentation (i.e. melasma, freckles, age-spots, and liver spots) and hyperpigmentation pose aesthetic problems [6] . Tyrosinase (monophenol, dihydroxy-L-phenylalanine: oxygen oxidoreductase, EC 1.14.18.1) catalyzes the hydroxylation of L-tyrosine to L-DOPA [3-(3, 4-dihydroxyphenyl)-l-alanine, monophenolase activity], which is further oxidized to dopaquinone, and then polymerizes spontaneously to form melanin [7] .
In folklore, sandalwood oil and paste have been used for centuries across many cultures worldwide to increase the fairness of skin and as a principal component of skin care formulations [8] . Besides, sandalwood oil is proven to have calming and relaxing effects in human beings [9] . However, there are no reports available to date, on the mode of action of sandalwood oil that relates to the aforementioned biological activities. Thus, we probed the tyrosinase and cholinesterase inhibition potentials of sandalwood oil, and its constituents. Towards this endeavor, we used two fast screening methods, inhibition of tyrosinase and cholinesterase by TLCbioautography, and compared these with the classical colorimetric inhibition assays.
The anti-tyrosinase activity was performed using a 96-well microtitre plate based spectrophotometric method using mushroom tyrosinase, a popular target enzyme for screening and characterizing potential tyrosinase inhibitors. Results revealed anti-tyrosinase potential for sandalwood oil (IC 50 , 174 µg mL -1 ), whereas the known tyrosinase inhibitors, kojic acid (IC 50 , 5.4 µg mL -1 ) and tropolone (IC 50 , 0.7 µg mL -1 ) showed stronger inhibition activities. Previous studies quoted an IC 50 value of 8.9 μg mL -1 for kojic acid, a reference inhibitor of mushroom tyrosinase [10] , and in this investigation, a comparable IC 50 value was obtained (5.4 μg mL -1 ). The anti-tyrosinase efficacy of sandalwood oil was comparable to that of a pure flavonoid compound, arbutin (IC 50 , 149 μg mL -1 ) [11] .
In the TLC-bioautography assay for tyrosinase inhibition, clear zones revealed inhibition of monophenolase activity when TLC plates spotted with sandalwood oil and positive controls (kojic acid and tropolone) were sprayed with L-tyrosine as substrate and tyrosinase. The main sandalwood oil constituent, α-santalol, (corresponding to R f =0.23) showed clear zones of inhibition as white spots on a dark background. A thorough observation also revealed that another three to four sandalwood oil constituents conferred such inhibitory activities, based on the clear zones. However, it could not be confirmed whether the second most abundant constituent, β-santalol (R f =0.88, not shown), was an active ingredient implicated in inhibition of tyrosinase.
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The major constituents of sandalwood oil are the sesquiterpene alcohols, α-santalol (53 %) and β-santalol (23 %) [12] . Thus, the 100 µg sandalwood oil loaded onto the TLC plate for screening must contain > 50 % α-santalol, i.e. ca. 50 µg. Results indicate that the inhibition potential of α-santalol at ca. 50 µg mL -1 was ~2.5 fold higher than kojic acid (1 µg mL -1 ), a strong tyrosinase inhibitor ( Table 1 ).
The 96-well microtitre plate based spectrophotometric method revealed the anti-cholinesterase potential of sandalwood oil, i.e. IC 50 of 4.8 µg mL -1 for AChE and 58 µg mL -1 for BChE inhibitions. Nevertheless, the positive control, physostigmine, showed much stronger inhibition activities, with IC 50 values of 0.01-0.02 µg mL -1 .
The AChE inhibition potential of sandalwood oil is ~11 fold higher than its BChE inhibition potential.
For the TLC-bioautography assay for cholinesterase inhibition, clear zones revealed inhibition of cholinesterase activity, when TLC plates were spotted with sandalwood oil and the positive control, physostigmine, while inhibitory potential could not be assigned for constituents in sandalwood oil except α-santalol. Results indicate that the inhibition potential of α-santalol at 50 µg mL -1 is comparable to, if not higher than physostigmine (1 µg mL -1 ), a strong cholinesterase inhibitor (Table 1) . Previously, essential oils from Melissa and Rosmarinus [13] , and monoterpenoids such as geraniol, 3-carene, α-caryophyllene, limonene, α-pinene, 1, 8cineole, and camphor were determined to have non-competitive and reversible, but significant AChE inhibitory activity. Moreover, αsantalol has particularly attracted increasing attention for its neuroleptic property [14, 15] , though there are no reports on the anticholinesterase potential of either sandalwood oil or its constituents. Reports suggest that compounds, by virtue of their hydrophobicity and cyclic nature, could be candidate cholinesterase inhibitors for future research, as the best feature associated with cholinesterase inhibition is a hydrophobic ligand making the hydrophobic active site of AChE susceptible to hydrophobic interactions [16] . Similarly, the results obtained in this work suggest that α-santalol has a combined pharmacological potential as a tyrosinase and cholinesterase inhibitor. Given that α-santalol constitutes approximately 50 %, v/v, of most sandalwood oils [17] , the pharmacological evaluation would be facilitated by bulk purification of this compound.
Results obtained from this investigation indicate that sandalwood oil and its chief constituent α-santalol show anti-tyrosinase and anticholinesterase potential. These activities probably relate to the mode of action of sesquiterpenoids of this essential oil for enhancing skin fairness and mental calming properties. The pharmacological evaluation would be facilitated if pure α-santalol were to be commercially available. The biological activities associated with sandalwood oil and α-santalol further extrapolate the biological activities associated with this important medicinal tree. Commercially available sandalwood oil procured from Cauvery TM (Government of Karnataka, Bangalore, India) was subjected to extensive HPTLC and GC analysis. The constituents (i.e. αsantalol) that were identified and purified were further used as authentic standards.
Experimental

Chemical reagents and materials:
High performance thin layer chromatography (HPTLC) analysis of sandalwood oil:
High performance thin layer chromatography (HPTLC) analysis for the detection, identification, and quantification of the sesquiterpenoid constituents of sandalwood oil was performed as described [18] . Cyclohexane: ethyl acetate (9:1) was used as the mobile phase. Constituents were identified based on their R f values compared with that of standards and absorption spectra. Quantitative evaluation was performed using peak areas with linear regression. Freshly prepared spray reagent [ethanolic solution of p-anisaldehyde (2.5%), sulfuric acid (3.5%), glacial acetic acid (1.6 %)], specific for sesquiterpenoids, was used for derivatization and detection of α-santalol (R f =0.23).
Tyrosinase inhibition assay by colorimetric method:
Tyrosinase inhibition assay for sandalwood oil and reference inhibitors (kojic acid and tropolone) was performed in a 96-well microplate format [19] using a Bio Rad microplate reader (Molecular Devices, CA, USA). Briefly, the samples were screened for o-diphenolase inhibitory activity of tyrosinase using L-DOPA as substrate. Samples were dissolved in Tween 80 (0.01%) to a range of varying concentrations (1000, 100, 10, 1, 0.1, 0.01, and 0.001 µg mL -1 ) for screening. Thirty units of mushroom tyrosinase (28 mM) was first pre-incubated with the test compounds in 50 mM Na-phosphate buffer (pH 6.8) for 10 min at 25°C. Then the L-DOPA (0.5 mM) was added to the reaction mixture and the enzyme reaction monitored by measuring the change in absorbance at 475 nm (at 37 °C) due to the formation of DOPAchrome for 10 min. The percent inhibition of the enzyme was calculated as follows: Inhibition (%) = [B -S/ B] x 100, where B and S were the absorbance for the blank and samples, respectively. After screening of the compounds, median inhibitory concentrations (IC 50 ) were calculated.
TLC bioautographic assay for tyrosinase inhibition:
The TLCbioautographic assay for cholinesterase inhibition was performed as described [20] . After application of sandalwood oil onto the TLC plates and development, aliquots of kojic acid and tropolone were spotted and the plate thoroughly dried for complete removal of solvents. Tyrosinase solution was prepared by dissolving 1 mL of 3333 U enzyme in 10 mL phosphate buffer. The substrate was prepared by dissolving 0.0036 g of L-tyrosine in 10 mL phosphate buffer. The plate was sprayed with l-tyrosine (2 mM) and incubated at room temperature for 10 min. Then the plate was sprayed with the tyrosinase solution and left at room temperature for 30 min. The background of the plate assumed a purplish-grey color and clear Anti-tyrosinase and anti-cholinesterase potentials of sandalwood oil Natural Product Communications Vol. 8 (2) 2013 255 white zones of tyrosinase-enzyme inhibition were observed, indicating the active compounds present in the samples.
TLC bioautographic assay for cholinesterase inhibition:
The TLC-bioautographic assay for cholinesterase inhibition was performed as described [21] . As described above, sandalwood oil and physostigmine (eserine) were spotted onto the plate and postrun as a positive control. 
Cholinesterase inhibition assay by colorimetric method:
Colorimetric assay for inhibition of cholinesterases was performed in 96-well microplates, as described previously [23], for sandalwood oil and physostigmine (positive control). Samples were dissolved in Tween 80 (0.01%) to a range of varying concentrations (1000, 100, 10, 1, 0.1, 0.01, and 0.001 µg mL -1 ). The assay buffer, 100 mM sodium phosphate buffer (pH 7.4) containing 0.1 bovine serum albumin, was mixed with 0.1 U of AChE (530 U mg -1 protein). After a short pre-incubation (i. e. 10 min), an aqueous mixture (100 μL) of 12.5 mM ATCI or BTCI and 10 mM DTNB (dissolved in 0.1 M NaCl and 0.02 M MgCl 2 ) were added to the wells. The absorbance was measured at 415 nm for 30 s initially, and again after 5, 10, 15, and 20 min of incubation of the enzyme. The percentage of cholinesterase inhibition was calculated by comparing the reaction rates (hydrolysis of the substrate) of the samples with the negative control. Reactions corresponding to the color change from yellow to orange on inhibition were detectable at 415 nm and the results were eventually expressed as IC 50 (µg mL -1 ).
Statistical analysis:
Data are presented as means of 3 independent inter-day experiments realized at least in triplicate. The IC 50 values were calculated by means of regression analysis.
